SCHEMBL4748527

SCHEMBL4748527

CCc1ccc(-c2c(-c3ccccc3)oc3ncnc(OCC(C)C[O])c23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 9/20 0.46
EGFR P00533 4/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HPGD P15428 1/20 0.45
UBE2N P61088 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TNK2 Q07912 2/20 0.45
CHEK1 O14757 3/20 0.43
JAK2 O60674 1/20 0.42
LCK P06239 1/20 0.42
SRC P12931 1/20 0.42
KDR P35968 1/20 0.42
ZAP70 P43403 1/20 0.42
JAK3 P52333 1/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
MAP2K1 Q02750 1/20 0.41
MERTK Q12866 1/20 0.41
RAD52 P43351 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4698505 1.00 AURKA (0.46) AURKAEGFRKDM4EALDH1A1HPGD
SCHEMBL4699368 1.00 AURKA (0.46) AURKAEGFRKDM4EALDH1A1HPGD
SCHEMBL6749032 0.88 AURKA (0.55) AURKAEGFRKDM4EALDH1A1HPGD
SCHEMBL4531686 0.88 AURKA (0.55) AURKAEGFRKDM4EALDH1A1HPGD
SCHEMBL4519987 0.88 CHEK1 (0.46) AURKAEGFRKDM4EALDH1A1HPGD
SCHEMBL4533456 0.88 CHEK1 (0.46) AURKAEGFRKDM4EALDH1A1HPGD
SCHEMBL4699375 0.87 KDM4E (0.43) AURKAEGFRKDM4EALDH1A1HPGD
SCHEMBL4533435 0.85 AURKA (0.52) AURKAEGFRKDM4EALDH1A1HPGD
SCHEMBL4532810 0.83 AURKA (0.48) AURKAEGFRKDM4EALDH1A1HPGD
SCHEMBL4527173 0.83 AURKA (0.43) AURKAEGFRKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008131858-A2 USE OF ACYCLICALLY SUBSTITUTED FUROPYRIMIDINE DERIVATIVES FOR TREATING PULMONARY ARTERIAL HYPERTONIA BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-11-06 WO disclosed